Clinical Trial Update: Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine

View source ↗

Summary

An update on quality-of-life outcomes for AIDS-related Kaposi sarcoma patients treated with bleomycin and vincristine, with results posted on 2022-07-25.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Kaposi Sarcoma
• HIV Infection

Drugs mentioned

• Bleomycin (bleomycin)
• Vincristine (vincristine)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: AIDS-Related Kaposi Sarcoma, Human Immunodeficiency Virus 1 Positive | Status: COMPLETED | Results posted: 2022-07-25